Systematic Review to Evaluate the Effectiveness of Emblica Officinalis for the Treatment of Periodontal Disease

Periodontal disease is a prevalent inflammatory condition characterized by plaque accumulation and gingival inflammation. Herbal interventions, particularly Emblica officinalis (Amla), have been explored as safe adjuncts to conventional therapy. The aim of the study was to systematically evaluate the effectiveness of E. officinalis , in various forms, on plaque and gingival indices in patients with gingivitis or mild-to-moderate periodontitis. A systematic search of PubMed, Scopus, Embase, Google Scholar, and clinical trial registries was conducted following the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines. Randomized controlled trials comparing E. officinalis interventions (gel, mouthwash, or irrigation) with placebo or conventional controls were included. Data on plaque index (PI) and gingival index (GI) were extracted and pooled using meta-analysis with standardized mean differences (SMD) and 95% confidence intervals. Risk of bias was assessed using the Cochrane tool. Three randomized control trails met the inclusion criteria. Meta-analysis showed no significant reduction in PI at baseline or 2 months, SMD: 0.12–0.33 ( P > 0.05), with high heterogeneity at 2 months. For GI, a moderate effect favoring E. officinalis was observed at 2 months SMD: 0.57 ( P = 0.004), but this was attenuated under random-effects modeling ( P = 0.052). Effects at 3 months were not statistically significant for either parameter. E. officinalis demonstrates potential as a short-term adjunct for reducing gingival inflammation, though its effect on plaque is less clear. Larger, standardized trials with longer follow-up are warranted to confirm efficacy.